Fig. 3From: Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumorCytotoxicity effect of SCF-DM1 on GIST cell lines. A Cell proliferation assay of GIST cells with treatment of drugs. B FACS detection of apoptosis in GIST cells with treatment of drugs. C Immunoblot analysis of apoptosis-related proteins of GIST cells with treatment of drugs. Lane 1: control; lane 2: SCF-DM1 25Â nM; lane 3: SCF-DM1 50Â nM; lane 4: DM1 250Â nM; lane 5: DM1 500Â nM; lane 6: imatinib 500Â nM. D Immunoblot analysis of p53 and p21 protein in GIST cells with treatment of SCF-DM1. E Total MDM2 expression of GIST 430 cells with treatment of drugs for 72Â h. F Cell cycle analysis of GIST cells with treatment of drugs. Numbers indicated G0/G1 or G2/M population (%). SCF-DM1: 50Â nM, DM1: 200Â nM. G Clonogenic assay of GIST cells with treatment of drugs. SCF-DM1: 50Â nM; imatinib: 500Â nM for GIST T1, 1000Â nM for GIST 430Back to article page